IDEAYA Biosciences, Inc. (IDYA)

38.22 +1.53 (+4.17%) USD  |  NASDAQ  |  Sep 28, 16:00
38.22 0.00 (0.00%) After-Hours: 17:28
More

IDEAYA Biosciences Cash from Operations (Annual) : -71.10M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for IDYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 -71.10M
December 31, 2024 -247.58M
December 31, 2023 -115.22M
December 31, 2022 -87.18M
December 31, 2021 -55.78M
Date Value
December 31, 2020 55.46M
December 31, 2019 -39.31M
December 31, 2018 -27.62M
December 31, 2017 -12.22M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
MediciNova, Inc. -9.810M
Ironwood Pharmaceuticals, Inc. 127.04M
Xencor, Inc. -135.12M
Viking Therapeutics, Inc. -278.68M
UroGen Pharma Ltd. -162.44M